Meet the Team
- CEO of Radiant Research/Synexus (10 years)
- Board Member of telehealth & translation companies.
VP of Operations VirTrial
- VP of Operations/New Site Development for Radiant Research/Synexus (19 years)
- Site base grew from 3 to 85 during tenure.
VP of BD
- Global BD Director for Radiant Research/Synexus (8 years)
- Founder and Operations Director for US site network, HUNT Services (7 years)
What is VirTrial?
The company vision is to replace 25-40 percent of standard clinical trial visits with decentralized clinical visits to create hybrid studies. This model is best suited for Phase III and IV studies, rare diseases and to replace traditional telephone calls within a protocol.
VirTrial enables higher performance by clinical trial sites, greater accessibility to trials for patients, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly.
Leadership team at Radiant Research, conducted >10,000 trials; felt site and patient challenges related to trial enrollment and retention.
Telehealth platform designed and implemented in healthcare.
VirTrial acquires proven telehealth platform; customized for clinical trials.
Pilot study conducted – Results confirm both site & patient-centric platform.
SCRS GIP announced; supporting site sustainability.
Collaboration with industry associations SCRS and ACRP to offer sites free Virtual Trial Capable training and certificates.
Enabled hyperCORE International to become the first Virtual Trial Capable site network in the world.
Launched VirTrial’s first FDA approved hybrid decentralized trial with Hope Biosciences.
Enabled Pratia to become the first Virtual Trial Capable site network in Europe.